Establishing a Robust Framework to Accommodate for the Increased Number of Clinical Stage Products
Time: 9:00 am
day: Day One AM
Details:
- Benchmarking progress made with Operation Warp Speed for Rare Diseases
- Accelerated approval: clarifying its use for gene therapies and advice for programs submitting for it
- Outlining the key ‘call to actions’ needed for the rare gene therapy field to advance
Speakers:
